Alto Neuroscience, Inc.
ANRO
$3.43
$0.020.59%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -2.53% | -7.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.18% | -7.77% | |||
| Operating Income | -19.18% | 7.77% | |||
| Income Before Tax | -16.72% | 0.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.72% | 0.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.72% | 0.21% | |||
| EBIT | -19.18% | 7.77% | |||
| EBITDA | -19.40% | 7.86% | |||
| EPS Basic | -16.62% | 1.23% | |||
| Normalized Basic EPS | -22.10% | 5.64% | |||
| EPS Diluted | -16.62% | 1.23% | |||
| Normalized Diluted EPS | -22.10% | 5.64% | |||
| Average Basic Shares Outstanding | 0.09% | 1.03% | |||
| Average Diluted Shares Outstanding | 0.09% | 1.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||